1. World Health Organization. Global Tuberculosis Report. WHO, Geneva, Switzerland. 2016.
2. World Health Organization. Molecular line probe assays for the rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy statement. WHO, Geneva, Switzerland. 2008; http://www.who.int/tb/laboratory/lpa_policy.pdf
3. Comparative Evaluation of GenoType MTBDRplus Line Probe Assay with Solid Culture Method in Early Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India;R N Yadav;PLoS ONE,2013
4. Use of the GenoType MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates;D Hillemann;J. Clin. Microbiol,2005
5. Hain Lifescience GmbH. Nehren, Germany. GenoType MTBDRplus, version 2.0 [product insert]. http://www.hain-lifescience.de/en/instructions-for-use.html